Aspira Women’s Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a report published on Thursday. The brokerage issued a hold rating on the stock.

Aspira Women’s Health Price Performance

AWH stock opened at $0.77 on Thursday. The company has a market cap of $12.75 million, a price-to-earnings ratio of -0.64 and a beta of 1.39. The company has a fifty day moving average price of $0.82 and a 200 day moving average price of $1.09. Aspira Women’s Health has a 12 month low of $0.67 and a 12 month high of $5.65.

Institutional Investors Weigh In On Aspira Women’s Health

A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. grew its position in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) by 33.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 316,294 shares of the company’s stock after purchasing an additional 79,898 shares during the period. B. Riley Wealth Advisors Inc. owned 1.90% of Aspira Women’s Health worth $256,000 at the end of the most recent quarter. Institutional investors own 12.19% of the company’s stock.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.